EFX.NYSEEquifax INC

Form 4: Equifax EVP, CISO & CTO Jamil Farshchi Reports Equity Grant and Stock Option Award

Sentiment:

SEC Form 4 Filing


Jamil Farshchi, EVP, CISO & CTO of Equifax Inc., reports the acquisition of common stock and stock options as part of the company's long-term incentive plan.

Summary

  • On February 10, 2025, Jamil Farshchi, EVP, CISO & CTO of Equifax Inc., acquired 3,707 shares of common stock.
  • These shares were awarded as an annual equity grant under the company's long-term incentive plan.
  • The restricted stock units vest 100% on February 10, 2028.
  • Farshchi also acquired 11,910 stock options with an exercise price of $252.90, also as part of the annual equity grant.
  • These options vest in three equal annual increments starting February 10, 2026.
  • Following the reported transactions, Farshchi beneficially owns 38,654 shares of Equifax common stock.
  • This includes accrued dividend equivalent units and 306 shares purchased through the Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. It's a neutral to slightly positive signal.

Positives

  • The equity grants and stock options align the executive's interests with the long-term performance of the company.
  • The vesting schedules encourage continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the equity grants.

Industry Context

Equity grants and stock options are common compensation practices for executives in publicly traded companies like Equifax, aligning their interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

  • Equity compensation packages for C-level executives at companies of Equifax's size and industry typically include a mix of restricted stock units and stock options.
  • Vesting schedules of three to four years for restricted stock and similar vesting periods for stock options are standard practice.
  • The specific amounts and terms of the grants would need to be compared against peer companies to determine if they are above, below, or in line with industry norms.

Stakeholder Impact

  • Shareholders may view the equity grants as a positive sign, aligning executive interests with company performance.
  • Employees may see the grants as part of a competitive compensation package, potentially boosting morale.

Key Dates

DateDescription
02/10/2025Date of the equity grant and stock option award.
02/10/2026First vesting date for the stock options (one-third).
02/10/2028Vesting date for the restricted stock units (100%).
02/10/2035Expiration date for the stock options.
02/12/2025Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.